Overview

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Status:
Active, not recruiting

Trial end date:
2020-09-01

Target enrollment:

Participant gender:

Summary

The study will evaluate the efficacy and safety of two different regimens of Conbercept (Treat-and-Extend (T&E) Regimen vs. Pro Re Nata (PRN)) in patients with wet AMD. This study is to provide long-term safety data in the treatment of patients with wet Age-related Macular Degeneration (AMD).

Phase:

Phase 4

Details

Lead Sponsor:

Xiaodong Sun

Collaborators:

Eye & ENT Hospital of Fudan University
Shanghai Tongji Hospital, Tongji University School of Medicine
Shanghai Zhongshan Hospital
The General Hospital of Central Theater Command